kliininen syöpätautioppi
Yhteystiedot
Henkilöt
Julkaisut
- Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI (2020)
- Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population (2021)
- Preterm children's developmental coordination disorder, cognition and quality of life: a prospective cohort study (2020)
- Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy (2022)
- Prognostic significance of DNA image cytometry in Libyan breast cancer (2012)
- Prognostic value of proliferation markers: Immunohistochemical Ki-67 expression and cytometric S-phase fraction of women with bresat cancer in Libya (2012)
- Prognostic value of tumour blood flow, [F-18]EF5 and [F-18]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy (2014)
- Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial) (2018)
- Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial (2016)
- Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer (2018)





